Chengdu Kanghong Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chengdu Kanghong Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Sihuan Pharmaceutical Holdings Group Ltd
sales of 2.92 billion Chinese Renmimbi [US$409.05 million]
of which 100%
was Pharmaceutical Prods),
Anhui Fengyuan Pharmaceutical
(3.01 billion Chinese Renmimbi [US$422.51 million]
of which 55%
was Medicine Manufacturing), and
Jinling Pharmaceutical Company Limited
(2.90 billion Chinese Renmimbi [US$406.48 million]
of which 60%
was Medicine Manufacture).
During the year ended December of 2018, sales at
Chengdu Kanghong Pharmaceutical Group Co Ltd were 2.92 billion Chinese Renmimbi (US$409.05 million).
increase of 4.7%
versus 2017, when the company's sales were 2.79 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Chengdu Kanghong Pharmaceutical Group Co Ltd
(and since 2013, sales have increased a total of 98%).
Sales of Pharmaceutical Manufacturing saw an increase
4.7% in 2018, from
2.79 billion Chinese Renmimbi to 2.92 billion Chinese Renmimbi.
Not all segments of Chengdu Kanghong Pharmaceutical Group Co Ltd experienced an increase in sales in 2018:
sales of Others fell 3.3% to 979,332.56 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).